Eastwood Bio-Medical Canada Inc. EBM.V
TSX
| 07/31/2026 | 04/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.42% | -3.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.42% | -3.64% | |||
| Cost of Revenue | 127.57% | -38.33% | |||
| Gross Profit | -30.57% | 12.38% | |||
| SG&A Expenses | -13.09% | 15.55% | |||
| Depreciation & Amortization | -1.32% | 1.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.14% | 1.16% | |||
| Operating Income | -33.73% | -20.29% | |||
| Income Before Tax | 0.00% | -224.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | -224.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -224.83% | |||
| EBIT | -33.73% | -20.29% | |||
| EBITDA | -44.14% | -27.36% | |||
| EPS Basic | 0.00% | -250.00% | |||
| Normalized Basic EPS | 0.00% | -300.00% | |||
| EPS Diluted | 0.00% | -250.00% | |||
| Normalized Diluted EPS | 0.00% | -300.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||